Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Chemours (CC) EBITDA (2016 - 2025)

Chemours (CC) has 12 years of EBITDA data on record, last reported at -$6.0 million in Q4 2025.

  • For Q4 2025, EBITDA fell 109.84% year-over-year to -$6.0 million; the TTM value through Dec 2025 reached -$77.0 million, down 124.06%, while the annual FY2025 figure was -$58.0 million, 363.64% down from the prior year.
  • EBITDA reached -$6.0 million in Q4 2025 per CC's latest filing, down from $81.0 million in the prior quarter.
  • Across five years, EBITDA topped out at $304.0 million in Q1 2022 and bottomed at -$396.0 million in Q2 2023.
  • Average EBITDA over 5 years is $72.2 million, with a median of $71.0 million recorded in 2024.
  • Peak YoY movement for EBITDA: plummeted 283.33% in 2023, then skyrocketed 1116.67% in 2024.
  • A 5-year view of EBITDA shows it stood at $204.0 million in 2021, then plummeted by 104.41% to -$9.0 million in 2022, then surged by 33.33% to -$6.0 million in 2023, then surged by 1116.67% to $61.0 million in 2024, then tumbled by 109.84% to -$6.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$6.0 million in Q4 2025, $81.0 million in Q3 2025, and -$205.0 million in Q2 2025.